Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
5.82
-0.78 (-11.82%)
At close: Jul 20, 2026, 4:00 PM EDT
5.81
-0.01 (-0.17%)
Pre-market: Jul 21, 2026, 4:15 AM EDT
Edesa Biotech Market Cap
Edesa Biotech has a market cap or net worth of $51.75 million as of July 21, 2026. Its market cap has increased by 207.05% in one year.
Market Cap
51.75M
Enterprise Value
41.75M
1-Year Change
207.05%
Ranking
Category
Stock Price
$5.82
ChartMarket Cap Chart
Since June 10, 2019, Edesa Biotech's market cap has increased from $37.12M to $51.75M, an increase of 39.42%. That is a compound annual growth rate of 4.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 51.75M | 337.31% |
| Dec 31, 2025 | 11.83M | 103.14% |
| Dec 31, 2024 | 5.83M | -59.72% |
| Dec 29, 2023 | 14.46M | -65.40% |
| Dec 30, 2022 | 41.80M | -45.08% |
| Dec 31, 2021 | 76.11M | 70.18% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 54.81M |
| MiNK Therapeutics | 53.66M |
| Veraxa Biotech AG | 53.46M |
| INmune Bio | 52.90M |
| Immutep | 51.58M |
| Xilio Therapeutics | 51.27M |
| BeyondSpring | 50.99M |
| Radiopharm Theranostics | 49.62M |